Implantable Microdevice In Primary Brain Tumors | MicrobiomeTrials← Back to trialsNCT04135807
Implantable Microdevice In Primary Brain Tumors
RecruitingEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2020-03-03Est. Completion: 2028-01-21
Enrollment target: 30 participants Locations- Brigham and Women's Hospital, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
BRAF V600 MutationLow-grade GliomaLow Grade Glioma of BrainRecurrent Low Grade Glioma
This phase II trial studies how well de-escalating the drugs dabrafenib and trametinib works in treating patients with l…
Birmingham, United StatesEst. completion Mar 31, 2032
Glioblastoma, IDH-Wildtype
This phase II trial compares the effect of adding WSD0922-FU to temozolomide versus temozolomide alone in slowing diseas…
Scottsdale, United StatesEst. completion Aug 31, 2036
Astrocytoma, IDH-Mutant, Grade 4Diffuse GliomaGlioblastoma, IDH-WildtypeSecondary Glioblastoma
This phase II trial studies the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with gliom…
Anchorage, United StatesEst. completion Jun 30, 2027